pepsico glp 1 Fortune Nepal | is facing mounting challenges in reviving growth as changing consumer habits, wider use of GLP-1 weight-loss drugs, and rising PepsiCo Bets on Lower Snack

Faster is not better and it raises your side-effect risk

The online pharmacies segment is expected to grow at the fastest CAGR from 2025 to 2032, propelled by increased digital adoption, convenience of home delivery, and telemedicine integration

Insurance coverage semaglutide often has broader approval

Abstract Despite the widespread use of metabolomics and proteomics to explore the molecular landscape of depression, there is a lack of consensus regarding dysregulated molecules with replicable evidence

PCAC member Elizabeth Rebello, a professor in the Department of Anesthesiology and Perioperative Medicine at the University of Texas MD Anderson Cancer Center, noted the "lack of efficacy data and randomized controlled trials" for these compounds